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A B S T R A C T
The IrisPlex system is a DNA-based test system for the prediction of human eye colour from biological
samples and consists of a single forensically validated multiplex genotyping assay together with a
statistical prediction model that is based on genotypes and phenotypes from thousands of individuals.
IrisPlex predicts blue and brown human eye colour with, on average, >94% precision accuracy using six
of the currently most eye colour informative single nucleotide polymorphisms (HERC2 rs12913832,
OCA2 rs1800407, SLC24A4 rs12896399, SLC45A2 (MATP) rs16891982, TYR rs1393350, and IRF4
rs12203592) according to a previous study, while the accuracy in predicting non-blue and non-brown
eye colours is considerably lower. In an effort to vigorously assess the IrisPlex system at the
international level, testing was performed by 21 laboratories in the context of a collaborative exercise
divided into three tasks and organised by the European DNA Proﬁling (EDNAP) Group of the
International Society of Forensic Genetics (ISFG). Task 1 involved the assessment of 10 blood and saliva
samples provided on FTA cards by the organising laboratory together with eye colour phenotypes;
99.4% of the genotypes were correctly reported and 99% of the eye colour phenotypes were correctly
predicted. Task 2 involved the assessment of 5 DNA samples extracted by the host laboratory from
simulated casework samples, artiﬁcially degraded, and provided to the participants in varying DNA
concentrations. For this task, 98.7% of the genotypes were correctly determined and 96.2% of eye colour
phenotypes were correctly inferred. For Tasks 1 and 2 together, 99.2% (1875) of the 1890 genotypes
were correctly generated and of the 15 (0.8%) incorrect genotype calls, only 2 (0.1%) resulted in
incorrect eye colour phenotypes. The voluntary Task 3 involved participants choosing their own test
subjects for IrisPlex genotyping and eye colour phenotype inference, while eye photographs were
provided to the organising laboratory and judged; 96% of the eye colour phenotypes were inferred
correctly across 100 samples and 19 laboratories. The high success rates in genotyping and eye colour
phenotyping clearly demonstrate the reproducibility and the robustness of the IrisPlex assay as well as
the accuracy of the IrisPlex model to predict blue and brown eye colour from DNA. Additionally, this
study demonstrates the ease with which the IrisPlex system is implementable and applicable across
forensic laboratories around the world with varying pre-existing experiences.
 2014 Elsevier Ireland Ltd. All rights reserved.1. Introduction
The ﬁeld of forensic genetics is making great strides with the
rapid scientiﬁc and technological evolution in obtaining new
knowledge and creating innovative tools for solving crimes more
and more effectively. Forensic DNA Phenotyping (FDP), a nascent
advancement in this ﬁeld, is one example of recent innovative
developments in forensic genetics and involves the prediction of an
individual’s externally visible characteristics (EVCs) using biologi-
cal samples obtained at a crime scene or from an anonymous body
(parts) that may belong to a missing person [1–4]. Conventional
DNA identiﬁcation involves the comparison of DNA proﬁles
derived from short tandem repeat (STR) marker genotypes
obtained from evidence and reference samples, which is useful
in cases when the sample donor is known from their DNA proﬁle. In
certain circumstances, sample donors may not be identiﬁed, i.e. a
match (or familial match) of the DNA proﬁles with known suspects
such as those in criminal offender DNA (proﬁle) databases or with
ante-mortem samples in cases of missing persons is not successful,
or when DNA proﬁle comparisons with putative relatives of
missing persons does not reveal the degree of similarities
indicating biological relationship. In these situations, FDP can be
used to help investigative authorities focus their search for
unknown suspects or missing persons towards individuals with
particular DNA-predicted externally visible phenotypes. The DNA-
based prediction of EVCs can thus aid investigations by police and
other authorities by reducing the number of possible suspects or
other individuals if conventional STR typing of the evidence fails to
produce identiﬁcation [1,2]. Furthermore, reconstructing appear-
ance information from biological samples such as bones or teeth or
other remains of deceased individuals is relevant in anthropologi-
cal research disciplines including those relying on ancient DNA
analysis [1,2,5].Several model-based approaches, amongst others [4,6], have
been developed for predicting a particular phenotype from DNA
most notably human eye (iris) colour [7]; the IrisPlex system is one
such tool [8]. IrisPlex can accurately predict blue and brown eye
colour with a precision of >94%, according to a previous study [9],
using six of the most informative eye colour markers: rs12913832
(HERC2), rs1800407 (OCA2), rs12896399 (SLC24A4), rs16891982
(SLC45A2 (MATP)), rs1393350 (TYR) and rs12203592 (IRF4) in a
single genotyping assay and a prediction model based on
thousands of individuals for which IrisPlex genotype and eye
colour phenotype data are available [7,8,10]. The 94% accuracy is
based on using a threshold of p > 0.7, however it is possible to use
IrisPlex prediction with a lower p > 0.5 threshold. The assessment
of precision accuracy is based on a broad European dataset of
>3800 individuals using IrisPlex can be found in Table 3 of that
publication [9]. The IrisPlex assay represents the ﬁrst FDP system
that successfully underwent developmental validation using the
Scientiﬁc Working Group on DNA Analysis Methods (SWGDAM)
guidelines for use in forensic casework [10]. The IrisPlex prediction
model, ﬁrst established on thousands of Dutch Europeans, has been
evaluated in several populations within and outside Europe and
was shown to perform reliably, independent of the bio-geographic
origin of the individual tested [9,11].
In an international effort to test the reliability and consistency
of the IrisPlex system for eye colour prediction through an inter
laboratory exercise, the European DNA Proﬁling (EDNAP) Group, a
working group of the International Society for Forensic Genetics
(ISFG), carried out a collaborative study led by the Department of
Forensic Molecular Biology of the Erasmus University Medical
Center Rotterdam (Netherlands), who initially developed and
validated the IrisPlex system [8–10] and for this reason were
chosen to conduct this further assessment on the IrisPlex tool
alone. Of the 21 participating laboratories, 18 were from Europe,
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this exercise was to implement the method and assess the
performance of the system across different forensic laboratories
with varying levels of experience, from complete novices with no
SNP typing experience to participants with SNaPshot experience
and those with speciﬁc IrisPlex experience.
Notably, some authors previously raised issues about marker
content and model outcomes of the IrisPlex system [12–15]. The
present collaborate EDNAP exercise, however, represents a rather
technical exercise to test the performance of the IrisPlex system
across laboratories with varying levels of pre-existing experience.
Therefore, issues about marker and model choice for predicting eye
colour from DNA may be addressed in more dedicated future
studies. Here, we present the results of this collaborative EDNAP
exercise, placing emphasis on the reliability and consistency in
using the IrisPlex system for blue and brown eye colour prediction
from DNA.
2. Materials and methods
2.1. Samples and materials provided to the participating laboratories
The organising laboratory (Department of Forensic Molecular
Biology, Erasmus MC University Medical Center Rotterdam,
Netherlands) divided the entire exercise into three different tasks.
All participants were provided with a detailed written laboratory
protocol [8] as well as the eye colour prediction model that is an
interactive excel spread-sheet as published earlier [10]. Further-
more, for assay interpretation guidelines, participants were given a
protocol stating a 50 relative ﬂuorescent units (rfu) peak height
threshold should be used for allele calls using the IrisPlex speciﬁc
GeneMapper software (Applied Biosystems) Bin and Panel set
provided. For a broader understanding of average peak heights and
balance ratios, participants were asked to refer to the previous
developmental validation publication of the IrisPlex system [10]. In
addition to the samples and the primers provided for each task, all
reagents, which include: 1 PCR buffer, 2.7 mM MgCl2, 200 mM of
each dNTP, 0.5 U AmpliTaq Gold Polymerase, SNaPshotTM Multi-
plex chemistry for the single base extension (SBE) reactions
(Applied Biosystems, Foster City, CA), Exonuclease Shrimp Alkaline
Phosphatase (ExoSAP-IT), and Shrimp Alkaline Phosphatase (SAP)
(USB Corporation, Cleveland, OH), required for running the IrisPlex
system were shipped on dry ice to each of the 21 participating
laboratories. The laboratories were asked to use their own internal
sizing standard (LIZ 120) and formamide for the capillary
electrophoresis run.Table 1
DNA extraction and quantiﬁcation protocols used by the 21 laboratories for both Tasks
Lab ID Ext raction Proto col 
1 
2 EZ1 DN A Inv estigat or  Kit on an EZ1  Advanced  XL (Qiagen) Quan
3 
4 Ta sk 1: EZ1  advanced ( Qiagen); Ta sk 3:DN A Blood  Mini Kit (Qiagen) ABI prism® 7900 (Life 
5 Chelex +  Qiaqu ick 
6 QIAam p® DN A Mini (Qiagen,  Hil den,  Germa ny) qPCR using  the 7900HT Fast R
7 Chelex 
8 5%  solution  of BT Chelex 100 r esin (Bio-R ad) Quantifil er® Hum 
9 QIAmp DN A blood  Mini kit from Qiagen Quantifil er® 
10 QIAmp DN A blood  Mini kit from Qiagen 
11
12 QIAamp  mini columns (Qiagen) real-time  
13 EZ1 robot (Qiagen) 
14 Qiagen EZ1  Advanced  XL extract ion robot with the EZ1 DN A Inv estigat or  Kit Quanti
15 QiAmp DN A Mini kit (Qiagen) 
16 QiAmp DN A Mini kit (Qiagen) 
17 Qiagen EZ1 Inv estigat or  Handboo k Ther
18 Appli ed B yosistem s Prepfil er  Forensic DN A Extract ion kit Ta 
19 Chelex Q
20 Pheno l–C hloroform Qua
21 Qiagen M48 r obotic stat ion  and  MagAtt ract  DN A Mini M48  Kit Due to an ExoSAP-ITTM degradation issue noted during the early
phase of the exercise, which subsequently was acknowledged by
the producing company as a bad batch of enzyme, aliquots of a
newly delivered and tested ExoSAP-ITTMwere shipped again to the
requesting laboratories, while the others opted to use their in-
house standard cleaning protocols. As this was a clean-up
procedure, it did not impede on the testing of the IrisPlex assay
overall. Puriﬁed products were run by the laboratories using their
in-house Genetic Analysers (for type, see Table 1) and analysed
with the previously published eye colour prediction model [10]
provided by the organising laboratory for predicting human eye
colour from IrisPlex genotypes.
As a disclaimer for the choice of samples used in this
assessment, please note that it is well established and documented
[7,9,16,17], that the IrisPlex system through its use of six eye colour
associated SNPs performs very well in predicting blue and brown
eye colour with Area Under the receiving operator Curve (AUC)
values >0.9; however its use for predicting intermediate eye colour
(current AUC of 0.7) is not at an optimum level yet. This is due to
the current lack of knowledge on DNA predictors for these non-
blue, non-brown eye colours i.e. green eye colour, individuals with
heterochromia etc. which is not only a limitation of the IrisPlex but
of all currently available DNA test systems for eye colour [4,6]. DNA
variants with similarly high prediction effects on non-blue/brown
eye colours as the IrisPlex SNPs have on blue and brown eye colour
have yet to be identiﬁed. Therefore, the IrisPlex system was
previously promoted for the prediction of blue and brown eye
colours and thus the organising laboratory opted to test variations
in blue and brown eye colour alone for Tasks 1 and 2 to evaluate the
current IrisPlex system assay and prediction performance on these
categories. Task 3 however incorporates all three categories as this
task was based on samples provided by the participating
laboratories who were not asked to focus on blue and brown
eye colour alone when selecting their Task 3 volunteers.
Tasks 1 and 2 contain samples from individuals of European
(80% per task) and non-European bio-geographic origin (20% per
task) including one admixed individual in Task 1. The individuals
used in Task 3, including information about their bio-geographic
background, were at the discretion of the participating laboratories
and were unknown to the organising lab.
2.2. Task 1 – IrisPlex eye colour prediction from biological samples
with eye colour knowledge
The organising laboratory provided all participating laborato-
ries with ﬁve blood samples (labelled Ind1–Ind5) and ﬁve saliva 1 and 2. Grey boxes indicate no data received from the participating laboratory.
Quantificat ion Proto col Polymer Genetic Analyzer
POP 4 3130 xl
tifil er® Duo DN A Quantificat ion  Kit (Life Techno logies) POP 6 310 0
POP 4 313 0
Techno logies-LT) u sing  Quantifil er® Huma n DN A Quantificat ion  Kit (LT). POP 4 3130 xl
Task 1: Qub it  and Ta sk 2: RT-PCR Quantifil er® POP 4 3130 xl
eal-time  PCR  System ( Appli ed B iosystem s,  Darmsta dt,  Germa ny)  and  Alu  Primers POP 4 3500 xl
Quantifil er® Duo POP 7 3130 xl
an DN A Quantificat ion  Kit (Life Techno logies) on  AB 7900 R T-PRC POP 4 313 0
Huma n kit on  Appli ed B iosystem s 7500 Real-Time  PCR Syste m POP 7 3500 xl
Nanodr op POP 7 3500 xl
Quantifil er® Huma n POP 4 3130 xl
quantitat ive PCR  ass ay using  ALU repeat s from Nicklas et  el. POP 7 3130 xl
Quantifil er® POP 7 3130 xl
fil er® Huma n DN A Quantificat ion  Kit (Life Techno logies) POP 4 3130 xl
Nanodr op POP 4 3130 xl
POP 7 350 0
mo Scientific NanoDrop 2000 /2000 c spect rophotomete r POP 4 313 0
sk 1 and Ta sk 3 a 1% agarose gel; Ta sk 2 - a RT PCR POP 4 313 0
uantifil er® DUO  in an 7500 Real-Time  PCR Syste m POP 7 313 0
ntifil er® Huma n DN A Quantificat ion  Kit and  AB 7300. POP 4 313 0
Quantifil er  kit® and  ABI 7500 POP 7 3130 xl
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blue (N = 5) or brown (N = 5) eye colour. To produce these samples,
fresh venous blood and saliva samples were collected from ten
different individuals and 100 mL of each of the samples were
pipetted on to the FTA cards. A digital eye image from each of these
10 individuals who donated blood or saliva was also provided to
the participants. All the laboratories were instructed to use their
own in-house DNA extraction and quantiﬁcation protocols. All
participating laboratories were asked to generate the IrisPlex
genotype proﬁle from each of the 10 samples and using the
provided IrisPlex prediction model, to conclude the eye colour
prediction of the 10 donor individuals by noting the probability
and precision accuracy per each sample and individual using the
guidelines implemented in a previous publication [9] as provided
to the participants. An example report was also provided to each
laboratory to ease the ﬁll-out for return. As the participants were
provided with eye pictures, they already knew the eye colour of the
study individuals of Task 1 before analyses. However, the
conclusion of the eye colour phenotypes had to be based on the
genotypes determined by each individual laboratory considering
the probability and precision accuracy guidelines provided by the
organising laboratory. The term ‘precision accuracy’ relates to the
previous publication [9], which undertook a study on the ﬁnal
prediction called by the IrisPlex model in terms of probability
values on over 3800 European individuals. It assesses the highest
probability value (which is deﬁned as the eye colour of the
individual) and how correct the eye colour prediction was at
thresholds that increase in increments of 0.05p; from no threshold
to p > 0.95 [9].
2.3. Task 2 – IrisPlex eye colour prediction from DNA of simulated
casework samples without eye colour knowledge
The laboratories were provided with ﬁve DNA samples
extracted from simulated casework samples (labelled CW1–
CW5) from 5 individuals with blue (N = 2) or brown (N = 3) eye
colour. DNA samples were extracted by the organising laboratory
with the QIAamp DNA mini kit (Qiagen, Hagen, Germany). The
following biological materials were used for DNA extractions: 2
buccal swabs (CW1 and CW2) – both samples subjected to UV
radiation using the Bio-Link (Vilber Lourmat) for 1 min at a
strength of 50 J/cm2 before DNA extraction; saliva on glass slide
(CW3) stored at room temperature for 1 week before DNA
extraction, whole blood on glass slide (CW4) stored at room
temperature for 1 week before DNA extractions, and semen DNA
extracted from a frozen donated sample (CW5). DNA concentra-
tions were measured using the nanodrop system and 3 mL of the
following solutions were provided: CW1: 0.5 ng/mL, CW2: 0.1 ng/
mL, CW3: 0.25 ng/mL, CW4: 2 ng/mL, and CW5: 50 ng/mL (see
Table 2 for overview). The samples CW1–CW4 were freshly
extracted, quantiﬁed and run using the IrisPlex system prior to
DNA degradation, thereby serving as a control to their degraded
counterparts. In contrast to Task 1, in Task 2 the laboratories were
not provided with any eye colour phenotype information of the
sample donors. Participants were also not provided with any other
sample information such as DNA concentration or treatment priorTable 2
Details of the simulated casework samples provided to the participating
laboratories for the Task 2.
Sample # Sample type Treatment Concentration (ng/mL)
CW1 Buccal Swab UV for 1 min 0.5
CW2 Buccal Swab UV for 1 min 0.1
CW3 Saliva on Slide RT for 1 week 0.25
CW4 Blood on slide RT for 1 week 2
CW5 Semen – 50to DNA extractions of the DNA extracts they received for Task 2.
They were asked to generate the IrisPlex genotype proﬁle for each
individual and report back the obtained eye colour probabilities
and accuracies using the model and materials provided, and to
ﬁnally conclude the most likely eye colour category per individual.
An example report was also provided.
2.4. Task 3 – participant-driven IrisPlex eye colour prediction
This part of the study was optional. Each participating
laboratory was instructed to collect and genotype samples from
ﬁve different individuals of any eye colour. Selection of volunteers
and biological materials was at the discretion of the participants.
An important caveat in this task is that IrisPlex cannot guarantee a
high prediction accuracy of the non-blue and non-brown eye
colours; however, in contrast to Tasks 1 and 2 no eye colour
phenotype restrictions were imposed on the participants in their
choice of volunteers for Task 3. The laboratories were asked to
report the DNA concentration, IrisPlex genotypes, eye colour
probability outcomes and accuracy percentages, and a digital high-
resolution eye image of the genotyped individuals. The organising
laboratory instructed that the iris photo should be taken in natural
light conditions (no ﬂuorescent bulb light) with and without ﬂash
lens using a digital camera focusing on eyes only (no full portrait).
3. Results and discussion
3.1. Sample extractions and quantiﬁcations by each participating
laboratory
As the DNA extraction and quantiﬁcation method can inﬂuence
genotyping outcomes due to the quality and quantity of DNA
extracted and consequently input into a downstream reaction, it
can thus inﬂuence phenotype inference from the genotypes
produced in FDP systems. Therefore we included extraction and
quantiﬁcation monitoring in this exercise. As part of Task 1, the
host laboratory provided the participating laboratories with
biological samples (blood and saliva samples on FTA cards) from
which the participants extracted and quantiﬁed DNA using their
methods of choice. To note, the afﬁliated laboratory number in the
author list does not represent the laboratory number described
throughout the paper. Protocols used for DNA extraction and
quantiﬁcation were different and are listed in Table 1. As evident,
the different extraction and quantiﬁcation methods used by the
participating laboratories provided varying results, as summarised
in a box plot diagram (Fig. 1), even though the same volume of
biological sample was provided to each of the participants on FTA
cards. Labs #2, 4, 13, 14 and 17 used the Qiagen EZ1 investigator kit
for extraction and reported on average higher quantiﬁcation values
as compared to Labs #6, 9, 10, 12 and 15 that used the Qiagen
QIAamp DNA mini kit extraction protocol. Lab #20 applied a
Phenol–Chloroform extraction approach, which yielded on average
higher quantiﬁcation values compared to all the other methods
used. Lab #18 used the Prepﬁler Forensic DNA extraction kit and
obtained on average higher ﬁnal DNA amounts than all other
methods, except Phenol–Chloroform. Labs #5, 7, 8, and 19, which
used the Chelex extraction protocol, reported comparatively lower
quantiﬁcation values than all other methods used in this exercise.
Worthy to note, this ﬁgure assumes that all laboratory input DNA
volumes were similar (i.e. the recommended 1 mL). The precise
extraction volumes used by all labs were not available to the
organising laboratory. This ﬁgure merely represents the differing
extraction methods yielding varying ﬁnal DNA concentrations,
however, it is expected that the participants followed all
recommendations provided by the organising lab which speciﬁ-
cally states a 1 mL volume with at least a concentration of 32 pg
Fig. 1. Box-plot (scaled to 3 ng/mL) showing the variation in obtained DNA concentrations using different methods for extraction and quantiﬁcation between the 21
laboratories for the 15 samples used in Task 1 and 2. Note that for Task 1 (samples Ind1–Ind10), biological samples were provided to the participants so that DNA extraction
and DNA quantiﬁcations were carried out by the participants on the same volumes of biological materials provided on FTA cards, while for Task 2 (samples CW1–CW5)
participants were provided with already extracted DNA samples that varied in treatment and DNA concentrations. Medians are represented by the horizontal lines and the
boxes depict the 25–75% quartiles. The whiskers represent the minimum and the maximum values. Outliers are marked with the laboratory number where they were
reported.
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Task 2 were previously extracted by the host laboratory using the
QIAamp DNA mini kit (Qiagen). The participating laboratories were
requested to measure DNA concentrations using their method of
choice and to report back the values. Because different quantiﬁca-
tion methods were used, the obtained concentration estimates
differed (Fig. 1 and Supplementary Table 1), similar to Task 1, even
though equal aliquots of the very same DNA solutions per each
sample were provided to each of the participants. As evident,
sample CW2 was recorded as the most variable (0.01–2.61 ng/mL),
which contradicts recorded measurements by the organising
laboratory of 100 pg (Fig. 1).
Supplementary material related to this article can be found, in
the online version, at doi:10.1016/j.fsigen.2014.04.006.
Overall, the recorded DNA quantiﬁcation data indicate that all
samples shipped, both the biological samples on FTA cards of Task
1 and the extracted DNA samples of Task 2, and remained rather
stable during transportation and short-term storage at the
participating laboratories. For the impact of the varying amounts
of DNA obtained by the participants in Task 1 and the varying DNA
concentration measures obtained in Task 2 on genotype and
phenotype accuracy, see the speciﬁc chapters on Tasks 1 and 2
below. From the DNA quantiﬁcation data reported by the
participating laboratories for the samples used in Task 3
(Supplementary Table 1) it is evident that all the samples
genotyped for this portion of the exercise were of reasonablequantity. When conducting genotyping analyses and calling the
peaks, the 50 rfu ﬂuorescence threshold was set for calling alleles
for a locus in all tasks and samples.
3.2. Task 1 – IrisPlex eye colour prediction from biological samples
with eye colour knowledge
All participating laboratories reported the predicted eye colour
and their probabilities in the format as requested by the organising
laboratory. Fig. 2 depicts the accurate genotype and eye colour
phenotype calls for all the ten samples as obtained by the 21
participating laboratories. Supplementary Table 2 lists the
genotypes of the ten individuals with their respective eye colour
probability and accuracy. Fig. 3 shows the eye colour images of the
10 individuals used in this task.
Supplementary material related to this article can be found, in
the online version, at doi:10.1016/j.fsigen.2014.04.006.
Twenty of the 21 laboratories (95%) predicted the eye colour of
all 10 individuals included in Task 1 correctly from IrisPlex (Fig. 2;
green bars). Overall, 208 (99%) of the 210 samples analysed in this
task by all the 21 laboratories were reported with the correct eye
colour phenotype prediction. An overview of the samples with
incorrect genotypes that were discordant with the organising
laboratory is provided in Table 3. Only one laboratory (Lab #3)
faced difﬁculties in concluding the correct eye colour phenotype
for two samples (Individual 1 and 10). The phenotype for both
Fig. 2. Accuracy of the IrisPlex genotype calls (6 SNPs) and the IrisPlex-based eye colour phenotype prediction of the 10 samples provided in Task 1 as reported by each of the
21 participating laboratories. Blue indicates the number of individuals that were correctly genotyped at all 6 IrisPlex SNPs (i.e. for which a correct IrisPlex proﬁle was
reported). Red indicates the total number of genotypes across all 6 SNPs and all 10 samples that were correctly reported. Green indicates the number of individual samples for
which the correct eye colour phenotype was reported. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of the
article.)
L. Chaitanya et al. / Forensic Science International: Genetics 11 (2014) 241–251246individuals was reported as inconclusive, although the correct
IrisPlex genotypes were obtained and reported. These two
individuals had eye colour probabilities for blue, intermediate
and brown of 0.306, 0.142, 0.552 and 0.299, 0.253, 0.448
respectively (Fig. 3(a) and (k)), and did not cause a problem for
the other 20 laboratories to conclude the correct brown eye colour
for both samples.
Overall, 1253 (99.4%) of the 1260 genotypes generated for the 6
IrisPlex SNPs in the 210 samples analysed by all the 21 laboratories
were reported correctly. The 7 (0.6%) incorrect genotypes were
reported by 4 laboratories, while 17 participants reported the
correct 6-SNP IrisPlex proﬁles for all 10 samples. Importantly, noneFig. 3. Eye colour images of the 10 individuals whose samples were used in Task 1 an
references to colour in this ﬁgure legend, the reader is referred to the web version of of these incorrect genotypes led to erroneous eye colour phenotype
predictions being reported. Lab #7 reported an incorrect homozy-
gous genotype T instead of the true heterozygous CT for
rs12203592 for Individual 8 due to a dropout of the C allele, since
the respective peak was below the 50 rfu threshold. Lab #12
reported discordant heterozygous instead of correct homozygous
genotypes for Individual 9 across three markers (rs12913832,
rs16891982 and rs1393350). Drop-in of the alleles C, G and T was
observed for each of the markers rs12913832, rs16891982 and
rs1393350 respectively. However, the DNA concentration for this
particular sample was reported by Lab #12 to be very low (0.02 ng/
mL), much lower than the concentration obtained by the otherd the 5 individuals whose samples were used in Task 2. (For interpretation of the
the article.)
Table 3
Tasks 1 and 2 genotyping results that were discordant between the host and the
participating laboratories.
Sample Lab# Locus Comments
Task 1 Individual 8 7 rs12203592 Drop-out of C
Individual 9 12 rs12913832 Drop-in of C
Individual 9 12 rs16891982 Drop-in of G
Individual 9 12 rs1393350 Drop-in of T
Individual 2 15 rs16891982 Drop-out of C
Individual 3 18 rs12203592 Drop-in of T
Individual 8 18 rs12203592 Drop-out of T
Task 2 CW2 6 rs12913832 Drop-out of T
CW2 7 rs12913832 Drop-out of C
CW2 15 rs1393350 Drop-in of T
CW2, CW3 17 rs12913832 Drop-out of T,
C respectively
CW2 17 rs1800407 Drop-out of A
CW3 18 rs1393350 Drop-out of T
CW2 21 rs12896399 Drop-out of T
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with the provided protocol, 1 mL of DNA solution of this sample was
used for the IrisPlex PCR. Therefore, for this sample the amount of
DNA input was below the previously established sensitivity
threshold of the IrisPlex assay [10], which explains the high failure
rate for genotypes of this sample. Lab #15 reported incorrect
homozygous genotype of the G allele (instead of the correct
heterozygous GC genotype) for individual 2 at rs16891982 due to a
dropout of the C allele. Lab #18 experienced at marker rs12203592 a
drop-in of allele T for individual 3 and dropout of allele T in
individual 8. One explanation could be primer degradation due to
incorrect storage of the primer or an incorrect volume addition of
this primer to the assay, but unlikely due to a sample issue as the
DNA concentrations reported for the individuals 2, 3 and 8 by the
Labs #15 and 18 were more than 1.1 ng/mL (provided that the
correct input of 1 mL was used). For cases such as these, an erroneous
result can be avoided by re-running several analyses of the sample,
and is usually recommended when using all genotyping platforms,
this includes the IrisPlex system.Fig. 4. Accuracy of the IrisPlex genotype calls (6 SNPs) and the IrisPlex-based eye colour ph
participating laboratories. Blue indicates the number of individuals that were correctly g
Red indicates the total number of genotypes across all 6 SNPs and all 5 samples that were
correct eye colour phenotype was reported. (For interpretation of the references to col3.3. Task 2 – IrisPlex eye colour prediction from DNA of simulated
casework samples without eye colour knowledge
In Task 2, the provided ﬁve DNA extraction aliquots from
simulated casework samples (Table 2) were evaluated by each
participating laboratory. Notably, the samples used for DNA
extractions not only came from different biological sources (saliva,
blood, and semen) but also experienced different environmental
conditions (UV radiation, storage at room temperature) and were
provided to the participants in varying DNA concentrations (0.1–
50 ng/mL), all unknown to the participants. Therefore, and due to the
fact that no eye colour phenotypes were provided of the sampled
individuals, this task was more challenging than Task 1. Fig. 4 depicts
the accurate genotype and eye colour phenotype calls for all the 5
samples as reported by the 21 participating laboratories. Supple-
mentary Table 2 shows the reported genotypes of the ﬁve samples
with their respective eye colour prediction probabilities and
precision accuracy. Fig. 3 shows the eye colour images of the 5
individuals used in this task. An overview of the samples with
incorrect genotypes that were discordant with the organising and
the other participating laboratories is provided in Table 3.
Eighteen (86%) of the 21 laboratories predicted the eye colour of
all 5 individuals correctly from IrisPlex (Fig. 4; green bars). Overall,
101 (96.2%) of the 105 samples analysed by all the 21 laboratories
together were reported with the correct eye colour phenotype. The 4
samples (3.8%) for which the eye colour phenotypes were incorrect
had been reported by 3 laboratories. Lab #3 predicted the eye colour
of 2 of the 5 individuals (CW2 and CW3) as inconclusive, although
the genotypes for these samples were reported correctly. Both
samples clearly had to be designated as brown from the obtained
probabilities (p = 0.448 and p = 0.552, respectively), and the
phenotypes indeed were brown (Fig. 3(l) and (m) respectively), as
was correctly interpreted by 18 other laboratories. The other 2
incorrectly phenotyped samples were reported by Labs #6 and 17
due to the drop-out of the T allele at rs12913832 in sample CW2. The
2 laboratories reported an incorrect homozygous C allele instead of a
heterozygous CT allele, thereby, reporting an incorrect blue eye
colour instead of the correct brown eye colour phenotype (Fig. 3(l)).enotype prediction of the 5 samples provided in Task 2 as reported by each of the 21
enotyped at all 6 IrisPlex SNPs (i.e. for which a correct IrisPlex proﬁle was reported).
 correctly reported. Green indicates the number of individual samples for which the
our in this ﬁgure legend, the reader is referred to the web version of the article.)
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IrisPlex SNPs in the 105 samples analysed by all laboratories
together were correctly reported in Task 2. The 8 (1.3%) incorrect
genotypes were produced in 2 samples (CW2 and CW3) by 6
laboratories, while 15 of the 21 laboratories (71.4%) reported the
correct 6-SNP IrisPlex proﬁle for all 5 samples. In contrast to the 2
(25%) genotype errors in sample CW2 by Lab #6 and 17 that caused
phenotype errors as mentioned in the previous paragraph, the
remaining 6 incorrect genotypes (75%) did not have any impact on
the eye colour phenotype accuracy. At rs12913832, Lab #7
reported an incorrect genotype due to a drop-out of the C allele
for sample CW2. A drop-in of the T allele for CW2 and drop-out of
the T allele for CW3 at rs1393350 resulted in incorrect genotyping
by Labs #15 and 18 respectively. Furthermore, incorrect genotypes
were reported by Lab #21 at rs12896399 for sample CW2 due to a
drop-out of the T allele. Lab #17 experienced problems in the ﬁrst
typing of samples CW1, 2 and 3 and subsequently retyped these
samples in different DNA dilutions. At rs12913832, drop-out of the
T allele for CW2 (as mentioned above); drop-out of the C allele for
CW3, and drop-out of the A allele at rs1800407 for CW2 were
reported which resulted in erroneous results for this laboratory. A
dilution step performed by the participating laboratory, due to a
misleading quantiﬁcation result, of the already low quantity
degraded samples provides a likely explanation for the drop-out of
the alleles in this set of samples.
Several laboratories (n = 3; Labs #3, 6 and 17) experienced
difﬁculties with correct phenotyping of the simulated and treated
casework samples in Task 2 for which no eye colour phenotypes
were provided as opposed to the untreated biological samples
provided together with eye colour phenotypes in Task 1 (n = 1; Lab
#3). Similarly, more laboratories (n = 6; Labs #6, 7, 15, 17, 18 and
21) had difﬁculties in correct genotyping of Task 2 samples in
relation to Task 1 samples (n = 4; Labs #7, 12, 15 and 18). Within
Task 2, the most genotyping and phenotyping difﬁculties i.e. allelic
drop-outs and drop-ins were reported for 2 particular samples
(CW2 and CW3). Sample CW2 was reported with different
incorrect genotypes by 5 of the laboratories (Labs #6, 7, 15, 17
and 21) and sample CW3 was reported incorrectly by 2
laboratories (Labs #17 and 18) (see Table 3 for overview). Sample
CW2 must therefore be noted as being a difﬁcult sample to
genotype. From Fig. 1, it is evident that, of the laboratories that
reported quantiﬁcation data for Task 2, sample CW2 was recorded
as the most variable (0.01–2.61 ng/mL), which strongly deviates
from the recorded measurements by the organising laboratory of
100 pg. Given its unusual quantiﬁcation range, severe degradation
and heterozygosity at 3 (rs12913832, rs1800407 and rs12896399)
of the 6 SNPs, increased incidence of allelic drop-out may be
expected in sample CW2 as compared to the homozygous sample
CW1 (which also experienced UV degradation) that caused no
problems for genotyping. This demonstrates, as expected and as
also known for any other genotyping assay, that the combination of
low quality and low quantity template DNA provides challenges for
correct genotyping including for the IrisPlex assay. However, it
should be emphasised that 244 of the 252 (96.8%) genotypes of the
most challenging samples CW2 and CW3 were generated correctly
by 15 of the 21 (71.4%) participating laboratories, which
demonstrates the reliability of the IrisPlex assay for difﬁcult
DNA samples. This also represents the necessity of employing
duplicate analysis when genotyping samples of low DNA quantity
in ﬁnal case work applications.
3.4. Task 3 – participant-driven IrisPlex testing
The optional Task 3 of the exercise, where participants were
asked to recruit their own volunteers for IrisPlex genotyping and
eye colour prediction, was performed by 20 of the 21 laboratories.Lab #7 could not perform this task due to reported ethical issues.
Supplementary Table 3 summarises the data for this task. Based on
the digital eye images provided by the participants (Fig. 5), the
organising laboratory judged the correct phenotypes by two
independent experienced observers. Lab #12 performed this
exercise and reported the genotype and phenotype, but provided
no eye images to the host laboratory for inspection. As it was not
possible to judge the accuracy of the results provided by this
participant, they were excluded from the analyses. As can be seen
in Fig. 6, 16 of the 19 laboratories (84.2%) predicted the eye colour
of all analysed individual samples correctly, while 3 laboratories
faced difﬁculties in concluding the correct eye colour from the
estimated probability combinations for some samples. Overall, 96
(96%) of the 100 samples analysed by the 19 laboratories were
reported with the correct eye colour prediction, as judged by the
organising laboratory based on the digital eye images sent by the
participants. The 4 samples reported with incorrect eye colour
were from 3 different laboratories (1x#2, 2x#3, and 1x#5). Lab #2
reported blue eye colour (p = 0.678) for their sample 1 but the eye
image showed brown colour and the estimated brown eye
probability was only 0.191 (Fig. 5(a)). Lab #3 obtained the
following probabilities for their sample 1: Blue – 0.207, Interme-
diate – 0.161 and Brown – 0.632 and reported an inconclusive
result, while the probability for brown was by far higher than for
the other two categories so that brown should have been
concluded instead and indeed the respective eye image showed
brown (Fig. 5(b)). Sample 4 of Lab #3 appeared blue from the
images (Fig. 5(c)) but a high brown eye probability (p = 0.892) was
obtained while the blue eye probability was low (p = 0.024). Lab #5
obtained probabilities of Blue – 0.375, Intermediate – 0.264 and
Brown – 0.361 for their sample 1, and reported blue eye colour but
the image indicates brown eye colour (Fig. 5(d)). In this case,
however, the eye colour could have been reported inconclusive
since the brown and the blue eye colour probabilities were very
similar. It is therefore important to use and report the level of
precision accuracy based on each probability threshold with the
ﬁnal prediction, i.e. p < 0.5 highest probability value, p > 0.5
highest probability value. This can be found in Table 2 of our
previous publication [9]. It is noteworthy to emphasise that the
IrisPlex genotypes in Task 3 were not veriﬁed independently in
contrast to those in Tasks 1 and 2. Therefore we cannot know for
sure if any of the 4 incorrect phenotype predictions in Task 3 may
have been caused by incorrect genotypes, although the high
genotyping accuracy rates achieved in Tasks 1–3 suggest this
might be somewhat unlikely. Due to violation of anonymity, the
geographic origin of these individuals cannot be determined.
Supplementary material related to this article can be found, in
the online version, at doi:10.1016/j.fsigen.2014.04.006.
Further to note, participants for Task 3 were not asked to
restrict their choice of volunteers to blue and brown eye colour
only. This was different from Tasks 1 and 2 where only volunteers
with blue and brown eye colour were used due to known
limitations of the IrisPlex system to accurately predict non-blue
and non-brown eye colours [8–10]. However only Lab #1 reported
2 individuals as intermediate (p = 0.411 and p = 0.405) and from
the eye images (Fig. 5(e) and (f) respectively), we can conﬁrm that
the individuals were correctly predicted as intermediate as they
contain substantial pupillary rings of a different colour (i.e.
majority of iris blue colour with obvious brown pupillary ring). It is
also worth noting that although no restrictions were imposed on
the choice of samples for Task 3, all the laboratories (except Lab #1)
chose individuals with either blue or brown eyes and hence it is
most likely that all the participants were guided by knowledge of
(or clearly considered the) limitations of IrisPlex for accurately
predicting non-blue and non-brown eye colour phenotypes.
Furthermore, according to general knowledge, the frequency of
Fig. 5. Eye images sent by the participating laboratories used for the voluntary aspect of the study, Task 3. Eye images include probability values for blue, intermediate and
brown eye colour provided by the participants as determined from the IrisPlex genotypes. The area surrounded by the red lines indicates the incorrect eye colour prediction as
assessed by the host laboratory from inspection of the eye images provided, and compared with the eye colour phenotype reported by the participants based on IrisPlex
analysis. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of the article.)
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Fig. 6. Accuracy of the IrisPlex-based eye colour phenotype prediction of the samples selected by all 19 laboratories participating in Task 3 (Lab #7 did not participate in this
task). Lab #12 though performed the task, did not include images and hence was not considered here. The correct eye colour phenotype was assessed by the host laboratory
from inspection of the eye images provided, and compared with the eye colour phenotype reported by the participants based on IrisPlex analysis. Blue indicates the number of
individuals that were genotyped and green indicates the number of individuals for which the correct phenotype was reported. (For interpretation of the references to colour in
this ﬁgure legend, the reader is referred to the web version of the article.)
L. Chaitanya et al. / Forensic Science International: Genetics 11 (2014) 241–251250blue and/or brown eyes is comparatively higher than intermediate
in the population, which could explain the rarity of volunteers with
intermediate eye colour phenotype used in Task 3.
The overall performances of the participating laboratories in all
3 tasks, is shown in Supplementary Table 4.
Supplementary material related to this article can be found, in
the online version, at doi:10.1016/j.fsigen.2014.04.006.
4. Conclusions
Overall, the high level of consistency achieved throughout this
collaborative effort in all 3 tasks illustrates the reliability of the
IrisPlex assay in producing highly accurate 6-SNP genotypes and of
the IrisPlex prediction model in producing accurate blue and
brown eye colour phenotypes from IrisPlex genotypes. As shown
here and previously [8], the IrisPlex assay provides reproducible
results despite differing levels of experience of the laboratory
personnel involved and differing DNA extraction and quantiﬁca-
tion methods used. The results obtained in this collaborative
exercise demonstrate the robustness and reproducibility of DNA-
based eye colour prediction when using the IrisPlex system in
different forensic laboratories world-wide. As emphasised before
[8–10], future focus shall be placed on improving DNA-based
prediction of non-blue and non-brown eye colours, for which theIrisPlex system is less suitable than for blue and brown eye colour
prediction from DNA.
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